Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.
about
Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@en
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@nl
type
label
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@en
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@nl
prefLabel
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@en
Pretreatment monocyte counts a ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Pretreatment monocyte counts a ...... d neck squamous cell carcinoma
@en
P2093
Ayako Endo
Daisuke Totsuka
Emiri Sato
Hiroyuki Ozawa
Junko Nagayama
Kaoru Ogawa
Keiko Soma
Koshiro Miura
Kosuke Uno
Marie Shimanuki
P2860
P304
18970-18984
P356
10.18632/ONCOTARGET.24863
P407
P577
2018-04-10T00:00:00Z